Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.

Anticancer research - 1 Jan 2000

Goutas Nikolaos, Vlachodimitropoulos Dimitrios, Bouka Myrto, Lazaris Andreas C, Nasioulas George, Gazouli Maria

Abstract excerpt

BACKGROUND: The genes RAS and BRAF have been shown to be frequently mutated in human thyroid carcinomas. The aim of this study was to genotype a cohort of 55 sporadic papillary thyroid carcinomas (PTC) and 44 sporadic medullary thyroid carcinomas (MTC) for the K-RAS codon 12 and BRAF codon 600 mutations. MATERIALS AND METHODS: K-RAS and BRAF mutations were characterized by an enhanced polymerase chain reaction...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Medullary
Share to Carcinoma, Papillary

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, ras

Share to Greece

Share to Paraffin Embedding

Share to Polymorphism, Restriction Fragment Length

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 18383861

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.PMID 18383861Read ↗

Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).Semantic proximity Read ↗

The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study.Semantic proximity Read ↗

BRAF mutations in Iranian patients with papillary thyroid carcinoma.Semantic proximity Read ↗

No correlation between BRAF<sup>V600E</sup> mutation and clinicopathological features of papillary thyroid carcinomas in TaiwanSemantic proximity Read ↗

BRAF mutations in an Italian cohort of thyroid cancers.Semantic proximity Read ↗

Correlation between <i>B-RAF</i> V600E mutation and clinico–pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literatureSemantic proximity Read ↗

High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.Semantic proximity Read ↗

Evidence of a Low Prevalence of <i>RAS</i> Mutations in a Large Medullary Thyroid Cancer SeriesSemantic proximity Read ↗

Specific pattern of RAS oncogene mutations in follicular thyroid tumors.Semantic proximity Read ↗

Prevalence of Ras mutations in thyroid neoplasia.Semantic proximity Read ↗

[BRAF V600E mutation in thyroid nodules in Argentina].Semantic proximity Read ↗

The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.